Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 517.00
Bid: 517.20
Ask: 517.60
Change: -10.80 (-2.05%)
Spread: 0.40 (0.077%)
Open: 529.80
High: 533.00
Low: 517.00
Prev. Close: 527.80
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

11 Mar 2020 07:00

RNS Number : 6960F
B&M European Value Retail S.A.
11 March 2020
 

 

 

 

11 March 2020

B&M European Value Retail S.A.

 

Sale of German Business

 

B&M European Value Retail S.A. (the "Company" or the "Group") announces that, following the strategic review in relation to the Group's German business, which was announced in November 2019, it has exchanged contracts today for the sale of J.A. Woll-Handels GmbH ("Jawoll").

 

The sale is for the Group's entire 80% shareholding (the "Shares") in Jawoll to a purchasing consortium led by AC Curtis Salta GmbH, a company funded by Adiuva Capital. The purchaser consortium also includes Wiebke Stern, Sebastian Dorin, Alexander Dorin, STIWEC GmbH and Jalogy Beteiligungs GmbH.

 

Completion of the transaction, which is conditional upon, among other things, German competition authority clearance being granted, is expected to occur within the next 28 days or by a long stop date of 1 June 2020.

 

Subject to completion, the total consideration payable to the Group for the transaction is €12,501,000 which is to be paid in cash. €2,501,000 is payable on completion of the transaction and €10,000,000 is payable on 31 December 2020 conditional on the on-going trading of Jawoll. In addition, on completion the purchaser's consortium will repay Jawoll's bank debt, which has a facility limit of up to €16m, and had been guaranteed by the Group.

 

The total consideration payable to the Group comprises:

(i) €2,500,000 as a part repayment of an intra-group trading account balance of €5,600,000 owed by Jawoll to the Group with the remaining balance having been waived;

(ii) €10,000,000 part repayment of loans made by the Group to Jawoll of €42,980,000 (including interest) with the balance of those loans having been waived; and

(iii) a nominal sum of €1,000 for the Shares.

Accordingly, the transaction will not have a material impact on the Group's leverage.

 

Jawoll, together with its wholly owned subsidiary, Jawoll Vertriebs GmbH ("Vertriebs"), is a general merchandise discount retailer with 89 stores in the North-West of Germany. The consolidated losses of those entities as reported for the financial year ended 31 March 2019 was £15.4m and the value of their Gross Assets as at 28 September 2019 (under IFRS16) was £192.6m.

 

The sale of Jawoll (together with its wholly owned subsidiary) constitutes a Class 2 transaction for the purposes of the UK Financial Conduct Authority's Listing Rules, and, as such does not require B&M shareholders' approval.

 

One of the purchaser's consortium, STIWEC GmbH ("STIWEC"), is an existing shareholder owning 13% of the shares of Jawoll. Another member of the purchaser's consortium, Jalogy Beteiligungs GmbH ("Jalogy"), is an investment company owned by Ralf Hartwich. Mr Hartwich is the Managing Director of Jawoll and Vertriebs and he is also an existing shareholder owning 7% of the shares of Jawoll. The transaction falls within the exemption in Listing Rule 11 Annex 1 Paragraph 9 of transactions to which the related party transaction rules do not apply, as it relates to shares in an insignificant subsidiary undertaking of B&M's Group.

 

The transaction does however constitute a related party transaction under the Luxembourg Law of 24 May 2011 (as amended on 1 August 2019). For the purpose of that law the Company confirms as follows. The related parties are STIWEC and Jalogy and the nature of their relationships with Jawoll and Vertriebs is as set out above in this Announcement. They have no other material relationships with the Company or any other entities in the B&M Group. The date of the transaction is the date of this Announcement. The value and net financial impact to the B&M Group of the transaction is as set out above in this Announcement. The sale transaction with the purchaser consortium includes the sale of 11% of the total issued shares in Jawoll to STIWEC and 8.45% of the total issued shares in Jawoll to Jalogy, for part of the nominal consideration (as referred to above in this Announcement) to be paid for the Shares. The transactions with those parties forms part of the terms of the overall sale transaction with the purchaser consortium, in respect of which the total consideration for the sale transaction is set out above. That consideration reflects the loss making position of Jawoll and its subsidiary as described above.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.

 

 

Enquiries

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive

Paul McDonald, Chief Financial Officer

Steve Webb, Investor Relations Director

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland

Daniel Yea

bmstores-maitland@maitland.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISJBMBTMTTBMLM
Date   Source Headline
18th Jul 202311:00 amRNSBlock Listing Application
13th Jul 20231:46 pmRNSBlock listing Interim Review
30th Jun 20239:00 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSQ1 FY24 Trading update
20th Jun 202310:01 amRNSBoard Appointment
20th Jun 20238:30 amRNSNotice of FY24 First Quarter Trading Statement
19th Jun 20237:00 amRNSAnnual Financial Report and Notices of AGM and EGM
13th Jun 20234:03 pmRNSDirector/PDMR Shareholding
31st May 20237:05 amRNSRetirement of Director after AGM
31st May 20237:00 amRNSFY23 Preliminary Results
22nd May 20236:08 pmRNSTR1- Notification of major holdings
21st Apr 202310:35 amRNSBoard Change
17th Apr 20234:28 pmRNSTiming of Preliminary Results Announcement
3rd Apr 20233:00 pmRNSNotice to Noteholders
3rd Apr 20232:59 pmRNSBank Facility Extension
16th Feb 20235:37 pmRNSPDMR Share Purchase
13th Jan 20231:09 pmRNSBlock listing Interim Review
11th Jan 20233:46 pmRNSDirector Dealing: Purchase of Bonds
10th Jan 20233:23 pmRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSStrong Q3 FY23 Trading
14th Dec 20221:59 pmRNSDirector Dealing: Purchase of Bonds
9th Dec 202211:43 amRNSNotice of FY23 Third Quarter Trading Statement
18th Nov 20229:14 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSHalf-year Report
2nd Nov 202212:06 pmRNSConfirmation of timing of Interim Results
31st Oct 20229:23 amRNSAppointment of directors- Result of Meeting
18th Oct 20223:51 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSTotal Voting Rights
27th Sep 20227:00 amRNSNotice of GM
15th Sep 20228:20 amRNSManagement Succession and Board Update
9th Sep 20222:17 pmRNSDirector/PDMR Shareholding
31st Aug 20223:06 pmRNSDirector/PDMR Shareholding
31st Aug 20223:01 pmRNSTotal Voting Rights
18th Aug 20227:00 amRNSBoard Appointment and Retirement
5th Aug 20224:41 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSAppointment of Joint Corporate Broker
3rd Aug 202212:12 pmRNSTR1 Notification
29th Jul 202210:28 amRNSAGM Voting Results
14th Jul 202212:07 pmRNSBlock Listing Application
13th Jul 20223:48 pmRNSBlock listing Interim Review
5th Jul 20227:00 amRNSBoard appointment
29th Jun 20227:00 amRNSQ1 FY23 Trading Update
21st Jun 20227:00 amRNSAnnual Financial Report and Notice of AGM
16th Jun 20229:55 amRNSHolding(s) in Company
9th Jun 20221:17 pmRNSHolding(s) in Company
9th Jun 202212:16 pmRNSDirector/PDMR grant of options
8th Jun 20227:00 amRNSDirector/PDMR Notice
31st May 20227:01 amRNSFY22 Preliminary Results
31st May 20227:00 amRNSCEO Succession
22nd Apr 20227:00 amRNSCEO Succession Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.